BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32424840)

  • 21. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
    Martin G
    J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.
    Zhang G; Cao Z; Wang P; Zhu L; Zhang L; Zho Z; Shi L; Wang X
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101605. PubMed ID: 31786334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.
    Gholam P; Weberschock T; Denk K; Enk A
    Dermatology; 2011; 222(4):358-62. PubMed ID: 21757880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
    Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
    Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
    Pei S; Kaminska ECN; Tsoukas MM
    Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
    Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
    Yazdanyar S; Zarchi K; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, Controlled Trial of Fractional Carbon Dioxide Laser Resurfacing Followed by Ultrashort Incubation Aminolevulinic Acid Blue Light Photodynamic Therapy for Actinic Keratosis.
    Alexiades M
    Dermatol Surg; 2017 Aug; 43(8):1053-1064. PubMed ID: 28394858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources.
    Giehl KA; Kriz M; Grahovac M; Ruzicka T; Berking C
    Eur J Dermatol; 2014; 24(3):335-41. PubMed ID: 24876164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
    Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
    Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
    Tanghetti EA; Hamann C; Tanghetti M
    J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
    Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
    Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.